HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13410378

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOENERGENIX LLC1700 OWENS STREET SAN FRANCISCO CA 94158

International Classification(s)

loading....
  • 2012 Application Filing Year
  • A61K Class
  • 11964 Applications Filed
  • 9694 Patents Issued To-Date
  • 81.03 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances201220132014201520162017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clare, Michael Skokie, US 96 925
McCall, John M Boca Grande, US 93 846
Romero, Donna L Chesterfield, US 69 752

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 3 Citation Count
  • A61K Class
  • 12.01 % this patent is cited more than
  • 13 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges842417611114322011046329171032401 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0250500750100012501500175020002250250027503000325035003750400042504500

Forward Cite Landscape

Load Citation